In 2016, there were 2.3 billion drinkers worldwide, and the hazardous use of alcohol cost 3 million lives globally, contributing to 5.3% of all fatalities as well as 132.6 million disability-adjusted life years (DALYs), or 5.1% of all DALYs in 2016. 1,2 So far, traditional pharmacotherapies such as acamprosate, naltrexone, disulfiram, and nalmefene have shown only moderate success in lowering…


Previous articleClearmind Announces Notice of Proposed Stock Consolidation
Next articleatai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01